DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

High-grade copper and gold intersections extend known mineralisation at FireFly’s Green Bay by 650m

The furthest intersection returns 49m at 6.1% CuEq1 and remains open at depth; These results will form part of the Mineral Resource Estimate update set for this quarterKEY POINTS Drilling from the end ...

Half-Yearly Results

Octopus Apollo VCT plc (‘Apollo’ or the ‘Company’) is a Venture Capital Trust (VCT) which aims to provide shareholders with attractive tax-free dividends and long-term capital growth by investing in a ...
New Zealand Science Media Centre

Committee recommendations on the Gene Tech Bill – Expert Reaction

The Gene Technology Bill continues to make its way through Parliament following feedback from the Health Select Committee.
BMJ

Neurological immune-related adverse events with checkpoint inhibitor therapy: challenges for the neurologist

For instance, in metastatic melanoma—a disease previously considered inevitably fatal—the combination of nivolumab with or without ipilimumab has demonstrated long-term efficacy, with ...